comparemela.com

Latest Breaking News On - கண் மேற்பரப்பு சமூகம் - Page 1 : comparemela.com

BAUSCH + LOMB LAUNCHES BIOTRUE HYDRATION BOOST LUBRICANT EYE DROPS AND BIOTRUE MICELLAR EYELID CLEANSING WIPES

New Preservative-Free and pH-Balanced Products Formulated for Irritated, Dry Eyes Now Rolling out to Major U.S. Retailers BRIDGEWATER, N.J., July 12, 2021 – Bausch + Lomb, a leading global eye health business, today announced the U.S. launch of Biotrue ® Hydration Boost Lubricant Eye Drops and Biotrue ® Micellar Eyelid Cleansing Wipes. Both products are preservative-free and uniquely formulated with naturally inspired ingredients to relieve symptoms associated with irritated, dry eyes. “One of the major culprits of dry eyes, which is one of the most common eye issues in the United States, 1 is our increasing usage of digital devices. We developed Biotrue ® Hydration Boost Lubricant Eye Drops and Biotrue

Ocuphire to Host Key Opinion Leader Event on Nyxol® as a Potential New Treatment Option for Reversing Pharmacologically Induced Mydriasis

Palatin Hosting Key Opinion Leader Webinar in Role of Melanocortin Agonists in Inflammation and the Treatment of Ocular Indications

Powerful prescription relief for ocular itch from allergic conjunctivitis

Powerful prescription relief for ocular itch from allergic conjunctivitis This article is sponsored by Eyevance Pharmaceuticals, developing innovative and impactful ophthalmic therapies for the ocular surface and anterior segment.  Allergic conjunctivitis (AC) is a common ocular condition. Worldwide, 15% to 20% of the population is affected by some form of allergic disease with ocular symptoms present in about 40% to 60% percent of those patients. More than a mere nuisance for many, ocular allergies have been shown to have an adverse impact on quality of life (QOL). In a cross-sectional study of 220 patients with ocular allergy, 25% had more than five episodes in the previous year and nearly 60% had episodes all year round. There was a significant impairment on overall QOL during an allergic conjunctivitis episode, with 46% rating their disease greater than 6 on a 10-point severity scale. Only 5.1% said their allergic conjunctivitis was mild or not severe. A total of 16% missed wo

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.